← FDA ENFORCEMENT
D-0511-2024Class I

Revive Rx LLC dba Revive Rx Pharmacy

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Revive Rx LLC dba Revive Rx Pharmacy
Product type
Drug
Status
Ongoing
Report date
2024-06-05
Distribution
USA Nationwide
Firm state
TX
Product quantity
751 vials
Initiated by
Voluntary: Firm initiated
Reason for recall

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

Product description

Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64

Code / lot info

Lot #: 748127, Exp 9/24/2024

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →